Minoryx publishes mechanism of action of leriglitazone in X-ALD in Science Translational Medicine journal

by Minoryx Therapeutics

Published data highlights therapeutic potential for all forms of X-ALD as well as other neurodegenerative and neuroinflammatory diseases

Read more

Covid-19 drives innovation and makes healthcare investment spike

by Biocat

Covid-19 pandemic has boosted cutting-edge research and innovation, reaching a record investment for companies in the BioRegion

Read more

Minoryx recibe la aprobación de la Agencia Reguladora Española para iniciar el estudio de fase 2 en la ataxia de Friedreich

by Minoryx Therapeutics

La ataxia de Friedreich es una enfermedad rara neurodegenerativa que se diagnostica antes de los 25 años. En España afecta a unas 2.000 personas. El ensayo FRAMES iniciará el reclutamiento de pacie...

Read more

Minoryx raises 1.6M€ in a round led by Caixa Capital Risc

by Expansión

La Caixa is leading this operation through the Caixa Innvierte BioMed II fund, joined by the Sanfilippo Foundation Switzerland

Read more
Subscribe to Directory
Write an Article

Recent News

Tuneable reverse photochromes in the sol...

A new technique allows the design of solid materia...

La Unidad de Chequeos de la Clínica sup...

El estudio realizado sobre una muestra significati...


Interview with Dámaso Molero, general m...

by 3P Biopharmaceuticals

Dámaso Molero: “There are great opportunities in Latin America for ...

A chip against chronic bacterial infecti...

by IBEC - Institut de Bioenginyeria de Catalunya

IBEC researchers develop a device that allows to grow biofilms and ana...

Photos Stream